- Title
- Phase I study of recombinant β ser 17 interferon in the treatment of cancer
- Creators
- G Sarna - Univ. California school medicine, dep. medicine, Los Angeles CA 90024, United StatesM Pertcheck - Univ. California school medicine, dep. medicine, Los Angeles CA 90024, United StatesR Figlin - Univ. California school medicine, dep. medicine, Los Angeles CA 90024, United StatesB Ardalan - Univ. California school medicine, dep. medicine, Los Angeles CA 90024, United States
- Publication Details
- Cancer treatment reports, Vol.70(12), pp.1365-1372
- Publisher
- National Institute of Health
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 3791249
- Record Identifier
- 991031725955702976
Journal article
Phase I study of recombinant β ser 17 interferon in the treatment of cancer
Cancer treatment reports, Vol.70(12), pp.1365-1372
1986
PMID: 3791249
Metrics
30 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.6 Immunology
- 1.6.106 Interferons
- Web Of Science research areas
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites